Why Distalmotion’s Roche sees Dexter’s small size as big advantage in the robotics surgical market

Why Distalmotion’s Roche sees Dexter’s small size as big advantage in the robotics surgical market
DeviceTalks Podcast Network
Why Distalmotion’s Roche sees Dexter’s small size as big advantage in the robotics surgical market

Apr 12 2024 | 00:40:44

/
Episode • April 12, 2024 • 00:40:44

Hosted By

Kayleen Brown Tom Salemi

Show Notes

In this episode of DeviceTalks Weekly, Greg Roche, CEO of Distalmotion, explains why smaller profile surgical robotic systems like Dexter have a shot at competing with established soft tissue giants. Just over two weeks to DeviceTalks Boston register now to meet Roche and other surgical robotics executives! Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.

Previous Episode

Can Sovato Health Build Digital Highway for Remote Robotic Surgery? Unpacking the Storz-Asensus News

Next Episode

Spencer Stiles on what's driving Stryker’s ortho growth with surgical robotics and strategic M&A

Other Episodes

July 18, 2013

Making the deal with CEOs from Zoll, NxStage Medical, Ocular Therapeutix and ConforMIS

MassDevice reporter Brad Periello speaks with CEO and founder of NxStage Medical Jeff Burbank, Zoll CEO Richard Packer, ConforMIS CEO Philipp Lang, and Ocular...

Play

00:40:28

May 21, 2021

How Atricure built a big business in Afib; A deep look into Abbott's new coronary imaging platform

This week, the DeviceTalks Weekly Podcasts delivers some learning. First, Dr. Nick West, CMO & divisional VP of global medical affairs at Abbott’s vascular...

Play

00:58:52

March 25, 2022

DTWEEKLY - CEO Lebed explains how Ukraine-based CRO is keeping trials running during invasion

In this episode of the DeviceTalks Weekly Podcast, we speak with Yuriy Lebed, the CEO of Pharmaxi LLC, a CRO based in Kyiv, Urkaine,...

Play

00:34:14